Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension Laurent Savale, MD, PhD, Jérôme Le Pavec, MD, PhD,

Slides:

Advertisements

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Advertisements

Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus Eric Hachulla, MD, PhD, Xavier Jais, MD, Gaël Cinquetti, MD, Pierre Clerson,

What Predicts Long-Term Survival After Heart Transplantation

Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor Marc Riquet, MD, PhD, Antoine Legras, MD,

Volume 153, Issue 1, Pages (January 2018)

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer Pierre-Benoit Pagès, MD, Pierre Mordant,

Long-Term Outcome and Valve Surgery for Infective Endocarditis in the Systematic Analysis of a Community Study Lauriane Pericart, MD, Laurent Fauchier,

Successful Surgical Management of Invasive Aspergillosis of the Pulmonary Arteries Giorgio Zanotti, MD, Salvatore Nicolardi, MD, Marco Morsolini, MD,

Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Long-Term Outcomes of En Bloc Resection of Non-Small Cell Lung Cancer Invading the Thoracic Inlet and Spine Elie Fadel, MD, Gilles Missenard, MD, Charles.

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Off-pump Bilateral Skeletonized Internal Thoracic Artery Grafting in Elderly Patients Takeshi Kinoshita, MD, Tohru Asai, MD, PhD, Tomoaki Suzuki, MD,

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Less Is More in Post Pediatric Heart Transplant Care

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Ho Young Hwang, MD, Jun Sung Kim, MD, Ki-Bong Kim, MD, PhD

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

The Annals of Thoracic Surgery

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Simultaneous Lung and Spine Impalement From a Fractured Humerus After Blunt Trauma Françoise Le Pimpec-Barthes, MD, PhD, Davy Ngabou, MD, Thierry Della-Siega,

Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation Steven A. Farmer, MD, PhD, Kathleen L. Grady,

Reversible Pulmonary Hypertension in Heart Transplant Candidates: To Transplant or Not to Transplant Stefan Klotz, MD, Frauke Wenzelburger, MD, Joerg.

Samuel P. Morreau, David A. Haydock, MBChB, FRACS

Who Do You Say You Are? The Annals of Thoracic Surgery

Saving Lives Is More Important Than Abstract Moral Concerns: Financial Incentives Should Be Used to Increase Organ Donation Benjamin Hippen, MD, Lainie.

Outcomes of Mechanical Valves in the Pulmonic Position in Patients With Congenital Heart Disease Over a 20-Year Period Hong Ju Shin, MD, Young-Hwue Kim,

Use of Amiodarone After Major Lung Resection

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Symptoms Are More Useful Than Echocardiography in Patient Selection for Pulmonary Endarterectomy Laura Donahoe, MD, Rachel Vanderlaan, MD, John Thenganatt,

Anomalous Origin of Left Pulmonary Artery From Left Subclavian Artery

Lei Yu, MD, Tianxiang Gu, MD, PhD, Zongyi Xiu, MD, PhD

Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database Mark Onaitis,

Lung Function and ECMO After Lung Transplantation

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Subclavian Artery Resection and Reconstruction for Thoracic Inlet Cancer: 25 Years of Experience Benoit Lahon, MD, Olaf Mercier, MD, PhD, Elie Fadel,

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Long-Term Survival and Freedom From Reoperation After Placement of a Pulmonary Xenograft Valved Conduit George M. Alfieris, MD, Michael F. Swartz, PhD,

Solitary Fibrous Tumor of the Pleura: Outcomes of 157 Complete Resections in a Single Center Benoit Lahon, MD, Olaf Mercier, MD, PhD, Elie Fadel, MD,

Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent? Raheel Rizwan, MD, Farhan Zafar, MD, Clifford Chin, MD, James Tweddell, MD,

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

MTP19-01: T4 N0/N1 nonsmall cell lung cancer can be cured as a first line treatment with an expected five year survival rate as high as 43% provided a.

David P. Mason, MD, Chase R. Brown, BS, Sudish C

Does Timing of Surgical Procedure After Neoadjuvant Chemoradiation Affect Outcomes in Esophageal Cancer? Williams Tessier, MD, Caroline Gronnier, MD,

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Dana Y. Fuhrman, DO, MS, Lan G

Pulmonary Embolectomy for Acute Massive Pulmonary Embolism

Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,

Susan D. Moffatt-Bruce, MD, PhD, John Karamichalis, MD, Robert C

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Posttraumatic Main Left Bronchial Rupture

Lung Transplantation and Coronary Artery Disease

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Justin P. V. Zachariah, MD, Frank A. Pigula, MD, John E

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Risk of Valve-Related Events After Aortic Valve Repair

Lung Cancer Invading the Pericardium: Quantum of Lymph Nodes

Presentation transcript:

Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension Laurent Savale, MD, PhD, Jérôme Le Pavec, MD, PhD, Olaf Mercier, MD, PhD, Sacha Mussot, MD, Xavier Jaïs, MD, Dominique Fabre, MD, Caroline O’Connell, MD, David Montani, MD, PhD, François Stephan, MD, Olivier Sitbon, MD, PhD, Gérald Simonneau, MD, Philippe Dartevelle, MD, Marc Humbert, MD, PhD, Elie Fadel, MD, PhD The Annals of Thoracic Surgery Volume 104, Issue 2, Pages 404-411 (August 2017) DOI: 10.1016/j.athoracsur.2017.02.034 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Study population and outcomes while on the waiting list. (CTEPH = chronic thromboembolic pulmonary hypertension; DLT = double-lung transplantation; HLT = heart-lung transplantation; HPL = high-priority list; PAH = pulmonary arterial hypertension; PVOD = pulmonary venoocclusive disease.) The Annals of Thoracic Surgery 2017 104, 404-411DOI: (10.1016/j.athoracsur.2017.02.034) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 (A) Cumulative incidence of death on waiting list or removal from the waiting list because of clinical worsening. (B) Cumulative incidence of transplantation in patients on the waiting list. (HPL = high-priority list.) The Annals of Thoracic Surgery 2017 104, 404-411DOI: (10.1016/j.athoracsur.2017.02.034) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Overall survival curve after double-lung or heart-lung transplantation in the periods before and after implementation of the high-priority list (HPL). The Annals of Thoracic Surgery 2017 104, 404-411DOI: (10.1016/j.athoracsur.2017.02.034) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Overall survival curve after listing for double-lung or heart-lung transplantation before and after implementation of the high-priority list (HPL). The Annals of Thoracic Surgery 2017 104, 404-411DOI: (10.1016/j.athoracsur.2017.02.034) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions